Medicated Skin Care in China

Date: February 28, 2012
Pages: 49
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M52399E497BEN
Leaflet:

Download PDF Leaflet

Medicated skin care is one of the most important OTC categories in China, with sales value reaching RMB7.7 billion in 2011, up by 11% from 2010. Increasing air and water pollution in China has led to more people suffering from chronic skin diseases in recent years. A mixture of improved education levels and rising disposable incomes in both urban and rural areas in China, coupled with negative environmental factors, drove medicated skin care sales over the review period.

Euromonitor International's Medicated Skin Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Paediatric Cough, Cold and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN CHINA

Euromonitor International
February 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Cr Sanjiu Medical & Pharmaceutical Co Ltd in Consumer Health (china)
Strategic Direction
Key Facts
  Summary 1 CR Sanjiu Medical & Pharmaceutical Co Ltd: Key Facts
  Summary 2 CR Sanjiu Medical & Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
  Summary 3 CR Sanjiu Medical & Pharmaceutical Co Ltd: Production Statistics 2011
Competitive Positioning
  Summary 4 CR Sanjiu Medical & Pharmaceutical Co Ltd: Competitive Position 2011
Xian Janssen Pharmaceutical Ltd in Consumer Health (china)
Strategic Direction
Key Facts
  Summary 5 Xian Janssen Pharmaceutical Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 6 Xian Janssen Pharmaceutical Ltd: Competitive Position 2011
Executive Summary
Consumer Health Market Continues Its Robust Growth
Rx-to-otc Switches Restarted in 2011
Further Consolidation of the Market
Chemists/pharmacies Still Dominate But Outpaced by Direct Selling in Growth
Steady Growth Is Anticipated Out of Steady Demand
Key Trends and Developments
Steady Economic Development Underpins the Consumer Health Market
Industry Leaders Continue To Consolidate the Market
Greying Population Fuels Sales
Market Segmentation Drives Sales of Vitamins and Dietary Supplements Products
the Restarting of Rx-to-otc Switches Impacts the OTC Industry
Territory Key Trends and Developments
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Sales of Consumer Health by Region: Value 2006-2011
  Table 13 Sales of Consumer Health by Region: % Value Growth 2006-2011
  Table 14 Consumer Health Company Shares 2007-2011
  Table 15 Consumer Health Brand Shares 2008-2011
  Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 20 Forecast Sales of Consumer Health by Region: Value 2011-2016
  Table 21 Forecast Sales of Consumer Health by Region: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 7 OTC - Switches 2009-2011
Sources
  Summary 8 Research Sources
Skip to top


Medicated Skin Care - Hong Kong, China US$ 900.00 Mar, 2011 · 27 pages
Medicated Skin Care in Taiwan US$ 990.00 May, 2012 · 28 pages
Medicated Skin Care in Lithuania US$ 990.00 Mar, 2012 · 27 pages
Medicated Skin Care in Macedonia US$ 990.00 May, 2012 · 23 pages

Ask Your Question

Medicated Skin Care in China
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: